This document examines the adoption of electronic health records among ambulatory care and long-term care providers in the United States using data from several national surveys from 2001-2009. It finds that in 2007, adoption of electronic medical record systems was highest among hospital outpatient departments and emergency rooms compared to physician offices. While basic systems were present for around 10-20% of providers, fully functional systems that could achieve meaningful use were only adopted by 2-4%. The document concludes that more widespread adoption is needed for many providers to qualify for financial incentives under the HITECH act, though existing basic systems could potentially meet many stage 1 meaningful use criteria.
Presentation for UP MSHI HI201 Health Informatics class under Dr. Iris Tan and Dr. Mike Muin. Check out my blog - http://jdonsoriano.wordpress.com/2014/10/09/fitting-the-pi…making-it-work/
Presentation for UP MSHI HI201 Health Informatics class under Dr. Iris Tan and Dr. Mike Muin. Check out my blog - http://jdonsoriano.wordpress.com/2014/10/09/fitting-the-pi…making-it-work/
INFORMATIVE TECHNOLOGY - ELECTRONIC HEALTH RECORD.pdfDolisha Warbi
definition, advantage of EHR, disadvantage of EHR, component, challenges of EHR, impact of EHR on care, EHR adoption model, stage of EHRAM framework, EHR system in clinical practice, use of EHR in nursing practice, future recommendation on EHR.
Health Information Exchange ( usage and benefits )Htun Teza
Presentation for RADS 601 ( Health Informatics and Health Information Technology ) - 20/11/19
Student of Master of Science in Data Science for Healthcare ( International Program ) ( Clinical Epidemiology and Biostatistics, Mahidol University, Thailand )
OCHWW @ BIO: The Bio Pharma Forum on ERx and EHROgilvy Health
Advancements in electronic health records (EHRs) have reached a critical mass. They provided consumers and physicians the platforms to help patients better afford and comply with their medicationsand healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access, and adherence to their medications. Find out what our experts found to be the most impactful takeaways to become a savvy brand that uses EHRs to reach our targeted audiences.
An electronic health record is the systematized collection of patient and population electronically stored health information in a digital format. These records can be shared across different health care settings.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
INFORMATIVE TECHNOLOGY - ELECTRONIC HEALTH RECORD.pdfDolisha Warbi
definition, advantage of EHR, disadvantage of EHR, component, challenges of EHR, impact of EHR on care, EHR adoption model, stage of EHRAM framework, EHR system in clinical practice, use of EHR in nursing practice, future recommendation on EHR.
Health Information Exchange ( usage and benefits )Htun Teza
Presentation for RADS 601 ( Health Informatics and Health Information Technology ) - 20/11/19
Student of Master of Science in Data Science for Healthcare ( International Program ) ( Clinical Epidemiology and Biostatistics, Mahidol University, Thailand )
OCHWW @ BIO: The Bio Pharma Forum on ERx and EHROgilvy Health
Advancements in electronic health records (EHRs) have reached a critical mass. They provided consumers and physicians the platforms to help patients better afford and comply with their medicationsand healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access, and adherence to their medications. Find out what our experts found to be the most impactful takeaways to become a savvy brand that uses EHRs to reach our targeted audiences.
An electronic health record is the systematized collection of patient and population electronically stored health information in a digital format. These records can be shared across different health care settings.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
1. Adoption of Health Information
Technology among U.S. Ambulatory
and Long-term Care Providers
by Esther Hing, M.P.H., and Anita Bercovitz, Ph.D
National Conference on Health Statistics
August 17, 2010
2. Background
•The 2009 American Recovery and Reinvestment
Act (ARRA) includes financial incentives for
physician practices and hospitals to adopt electronic
health record (EHR) systems starting in 2011. ARRA
also includes disincentives for not adopting these
systems starting in 2015.
•Incentives include $19 billion in Medicare and
Medicaid payments to physicians and hospitals
demonstrating “meaningful use” of EHR systems.
3. Objectives
•Examine use of electronic medical record (EMR)
systems among ambulatory and long-term care
providers in 2007, the most recent year with
comparable data, as well as other settings with
available data.
•Examine availability of basic electronic health
record (EHR) systems and fully functional EHR
systems among physicians and hospital
departments, as well as selected estimates of
“Meaningful use”.
4. Data sources
Survey Type of provider Data year
analyzed
Average
responding
sample size
Data collection
method
NAMCS Office-based
physician
2001-2009 1,500 physicians Personal interview
and mail survey in
2008-2009
NHAMCS Hospital
outpatient
department (OPD)
and emergency
departments (ED)
2006-2007 480 hospitals Personal interview
NSAS Ambulatory
surgery centers
2006 490 facilities Personal interview
NNHS Nursing homes 2004 1,200 nursing
homes
Computer-
assisted personal
interview
NHHCS Hospices and
home health
agencies
2007 1,000 agencies Self-administered
questionnaire and
computer-assisted
personal interview
5. Percent of ambulatory and long-term care providers
using electronic medical record systems, 2007
1/ Difference with hospital emergency department is statistically significant.
2/ Difference with hospital outpatient department is statistically significant.
SOURCES: CDC/NCHS, National Ambulatory Medical Care Survey, National Hospital Ambulatory
Medical Care Survey, National Home and Hospice Care Survey.
6. Percent of ambulatory and long-term care providers
with types of electronic record systems, 2007
* Figure does not meet standards of reliability or precision.
SOURCES: CDC/NCHS, National Ambulatory Medical Care Survey, National Hospital Ambulatory
Medical Care Survey, National Home and Hospice Care Survey.
*
*
7. Other estimates of electronic medical
record system use
Survey Type of
provider
Data year
analyzed
Percent of
providers
using
electronic
medical
record
systems
Percent of
providers
with basic
systems
National
Survey of
Ambulatory
Surgery
Freestanding
ambulatory
surgery
centers
2006 22.3% 3.2% *
National
Survey of
Ambulatory
Surgery
Hospital-
based
ambulatory
surgery
centers
2006 62.4% 18.6%
National
Nursing Home
Survey
Nursing
homes
2004 42.7% 19.9%
NOTE: * Figure does not meet standards of reliability or precision.
8. Percent of hospital outpatient and emergency departments
with types of electronic record systems, 2006 and 2007
+ Difference between 2006 and 2007 is statistically significant (p<0.05).
* Figures does not meet standards of reliability or precision.
NOTES: OPD is outpatient department, ED is emergency department.
SOURCE: CDC/NCHS, National Hospital Ambulatory Medical Care Survey.
*
*
*
+
+
*
9. Percent of office-based physicians with types of electronic
record systems, selected years
18.2 17.3 17.3
20.8
23.9
29.2
34.8
41.5
10.5
11.8
16.7
3.1 3.8 4.4
0
5
10
15
20
25
30
35
40
45
2001 2002 2003 2004 2005 2006 2007 2008 2009
Percent
of
physicians
Electronic medical
record system
Basic system
Fully functional
system
43.9
20.5
6.3
NOTE: 2009 estimates are preliminary and are based on a mail survey. 2008
estimates includes personal interview and mail survey data.
SOURCES: CDC/NCHS, National Ambulatory Medical Care Survey.
10. Demonstrating Stage 1
“Meaningful Use”
•Stage 1 requirements
•Use of certified EHR technology
•Physician reports on 15 Core Set and 5 of 10 Menu
Set Measures.
•All 15 Core Set Measures need to be
demonstrated
•Menu Set includes 5 of 10 tasks providers can
choose to implement
11. Preliminary percentage of office-based physicians with
basic systems using function needed to meet selected
Stage 1 Meaningful Use (MU) criteria
1/ MU criteria: More than 50% of patients’ demographic data recorded as structured data.
2/ MU criteria: More than 80% of patients have at least entry recorded as structured data.
3/ MU criteria: More than 30% of patients have at least one Rx ordered through computerized provider order
entry (CPOE).
4/ MU criteria: Drug-drug and drug-allergy interaction alerts enabled.
5/ MU criteria: More than 40% of prescriptions transmitted electronically.
6/ MU Menu Set criteria: More than 40% of lab test results incorporated into EHR as structured data.
NOTE: Estimates based on 20.5% of office-based physicians with basic systems.
SOURCE: CDC/NCHS, 2009 National Ambulatory Medical Care Survey.
12. Conclusions
• In 2007, adoption of EMR systems among hospital OPDs
(49.8%) and EDs (61.6%) was at a higher level than
among physicians (34.8%).
• Basic systems were available more frequently among EDs
(19.1%) than in physician offices (11.8%) or OPDs (9.1%);
this suggests hospitals adoption of these systems vary by
department.
• Availability of fully functional systems was low in all three
settings (2.0% to 3.8%) in 2007.
• Use of EMR, basic, and fully functional systems among
hospital-based ambulatory surgery centers (ASCs) in 2006
followed a similar pattern as EDs in 2007.
• Availability of basic systems in long-term care settings is
similar to availability in physician offices.
13. Conclusions
• Based on 2009 NAMCS estimates, it appears most
physician offices with basic systems can meet Stage 1
“Meaningful Use” (MU) criteria.
• However, only 84.5% of physicians reported using the
drug alerts for drug interactions or contraindications.
• Ability of basic systems to exchange data with other health
providers is problematic: Although 95.9% of physicians
with basic systems used CPOE to order prescriptions, only
70.9% transmitted prescriptions to pharmacy
electronically.
14. Policy implications
• As of 2009, 20% or less of physician offices and hospital units (EDs,
OPDs, and hospital-based ambulatory surgery centers) had adopted
a basic EHR system; more widespread adoption is needed for many
of these providers to demonstrate “meaningful use” of EHR systems.
• Based on 2009 NAMCS estimates, it appears most physician offices
with basic systems potentially could meet Stage 1 “Meaningful Use
(MU)” criteria.
• Actual percentage of patients that MU criteria was applied to,
however, was not collected. For example, we did not collect the
percent of prescriptions ordered using CPOE, nor the percent of
patients with entries as structured data.